Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | CYP4F2 | P78329 | 3/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.50 |
| ▸ | LPL | P06858 | 1/20 | 0.48 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL40656 | 0.85 | CA2 (0.77) | CA2TAAR1TDP1CYP4F2CYP4A11 | |
| SCHEMBL79488 | 0.84 | CYP4A11 (0.57) | CA2TAAR1CYP4F2CYP4A11LPL | |
| SCHEMBL7643947 | 0.83 | CA2 (0.59) | CA2TDP1CYP4F2CYP4A11LPL | |
| SCHEMBL9208507 | 0.82 | CYP4A11 (0.58) | CA2TAAR1CYP4F2CYP4A11LPL | |
| SCHEMBL6057959 | 0.82 | CA2 (0.72) | CA2TDP1CYP4F2CYP4A11CA12 | |
| SCHEMBL6546733 | 0.82 | TAAR1 (0.68) | CA2TAAR1TDP1LPLLIPG | |
| Alcohol SCHEMBL27952977 | 0.82 | LPL (0.57) | CA2TAAR1TDP1LPLLIPG | |
| Ammonia Solution, Strong SCHEMBL9651935 | 0.81 | CA2 (0.56) | CA2TDP1CYP4F2CYP4A11LPL | |
| SCHEMBL9027695 | 0.80 | CYP4A11 (0.56) | CA2TAAR1CYP4F2CYP4A11LPL | |
| SCHEMBL16807165 | 0.80 | BACE1 (0.42) | CA2TAAR1TDP1CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1039411-A | The short residence time(SRT) evaporation of right-acetoxyl phenylmethylcarbinol | HOECHST CELANESE CORP (US) | 1990-02-07 | — | — | CN | claimed |
| WO-2024077298-A1 | DURABLE GRAPHENE OXIDE MEMBRANES COMPRISING FUNCTIONALIZED SUPPORT COMPONENTS | VIA SEPARATIONS, INC. (US) | 2024-04-11 | — | — | WO | disclosed |
| US-20230150974-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-18 | — | — | US | disclosed |
| CN-112047797-B | Method for preparing alpha-alkyl substituted ketone compound | 赣南医学院 | 2023-04-07 | — | — | CN | disclosed |
| US-20220362396-A1 | AMINO-PYRAZINECARBOXAMIDE COMPOUNDS, CONJUGATES, AND USES THEREOF | SILVERBACK THERAPEUTICS, INC. | 2022-11-17 | — | — | US | disclosed |
| EP-3656403-B1 | PREPARATION PROCESS OF PSMA BINDING LIGAND-LINKER CONJUGATES | PURDUE RESEARCH FOUNDATION (US) | 2022-05-11 | — | — | EP | disclosed |
| WO-2022026823-A1 | CDK19-SELECTIVE INHIBITORS, AND METHODS OF USE THEREOF | CHAN ZUCKERBERG BIOHUB, INC. (US) | 2022-02-03 | — | — | WO | disclosed |
| EP-3906969-A1 | ANTIHYPERTENSIVE POLYOL COMPOUND AND DERIVATIVE THEREOF | East China University of Science and Technology (CN) | 2021-11-10 | — | — | EP | disclosed |
| WO-2021102332-A1 | TGFBETAR2 INHIBITOR-LRRC15 ANTIBODY CONJUGATES AND USES THEREOF | SILVERBACK THERAPEUTICS, INC. (US) | 2021-05-27 | — | — | WO | disclosed |
| CN-112047797-A | Method for preparing alpha-alkyl substituted ketone compound | 赣南医学院 | 2020-12-08 | — | — | CN | disclosed |
| US-5091422-A | Treating inflammatory or allergic skin disease, lowering gastric acidity | GLAXO GROUP LIMITED (GB) | 1992-02-25 | — | — | US | disclosed |
| EP-0454501-A2 | Benzylidenethiazolidine derivatives, their preparation and their use for the inhibition of lipid peroxides | Sankyo Company Limited (JP) | 1991-10-30 | — | — | EP | disclosed |
| US-4992474-A | Adrenergic stimulants | GLAXO GROUP LTD. (GB) | 1991-02-12 | — | — | US | disclosed |
| EP-0393607-A2 | Phenylcarboxylic acid derivatives having a hetero ring | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-10-24 | — | — | EP | disclosed |
| EP-0368670-A1 | Trisubstituted piperazine compounds, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1990-05-16 | — | — | EP | disclosed |
| EP-0192111-B1 | ISO-UREAS, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS HERBICIDES | BASF Aktiengesellschaft (DE) | 1990-05-16 | — | — | EP | disclosed |
| EP-0191394-B1 | ISOTHIOUREAS, PROCESS FOR THEIR PREPARATION AND THEIR USE TO COMBAT UNDESIRABLE PLANT GROWTH | BASF Aktiengesellschaft (DE) | 1989-12-06 | — | — | EP | disclosed |
| US-4692187-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1987-09-08 | — | — | US | disclosed |
| US-4689068-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1987-08-25 | — | — | US | disclosed |
| EP-0192111-A1 | Iso-ureas, processes for their production and their use as herbicides | BASF Aktiengesellschaft (DE) | 1986-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150974-A1 | COMPOUNDS AND USES THEREOF | VHL, CLN6, TFEB | CA2 4715/4885TAAR1 4538/4885TDP1 725/4885 |
| US-20220362396-A1 | AMINO-PYRAZINECARBOXAMIDE COMPOUNDS, CONJUGATES, AND USES THEREOF | TGFBR2, SMAD2, ACVR2A | CA2 2677/4885TAAR1 903/4885TDP1 4328/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.